Cancer Treatment

Proton therapy expansion to put India high on global cancer care map

Rising capacity, cost advantage, and new centres position India as a key destination for advanced cancer care, though access gaps and affordability remain challenges

Israel PM Netanyahu says he underwent successful prostate cancer treatment

The tumor was discovered during a routine check-up after surgery for an enlarged benign prostate a year and a half ago, he said

What are the best plans that insurers offer for cancer treatment?

With cancer treatment costs rising, insurers are offering specialised plans that provide staged payouts, long-term financial protection and support across diagnosis and recovery

Why egg and sperm freezing needs urgent attention in cancer care

As cancer treatments improve survival, experts stress early fertility discussions and preservation options so patients can make informed choices about life after treatment

This small shrinking organ may shape cancer survival and ageing risk

New research finds the thymus remains active in adults and may influence immunity, cancer outcomes and ageing risk, with stronger thymus function linked to better survival and lower disease burden

Researchers reprogram natural killer cells to attack cancer faster

A new study shows that tweaking natural killer cells and briefly treating them with a cancer drug helped them destroy blood cancer cells more effectively in lab and animal tests

AstraZeneca gets Indian regulator's nod to market cancer drug Imfinzi

AstraZeneca Pharma India Ltd on Tuesday said it has received permission from India's drug regulator to market Durvalumab solution for infusion used in cancer treatment for an additional indication. The company has received permission from the Central Drugs Standard Control Organisation, Directorate General of Health Services, to import for sale and distribution of Durvalumab solution for infusion of strengths 120 mg/2.4 ml and 500 mg/10 ml (brand name Imfinzi) for an additional indication, AstraZeneca Pharma said in a regulatory filing. Through this approval, Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy, followed by maintenance treatment with Durvalumab as monotherapy in endometrial cancer which is mismatch repair deficient (dMMR). The receipt of this permission paves way for the marketing of Durvalumab solution for infusion 1

Only 34% of day care cancer centres approved for FY26 are functional

Just 102 of the 297 day care cancer centres approved for FY26 are operational so far, with states such as Telangana, Bihar and Karnataka reporting a higher share of functional facilities

AI analysis shows fake studies may be flooding cancer research worldwide

A machine learning study has flagged more than 260,000 cancer research papers worldwide as potentially linked to paper mills, raising serious concerns about the reliability and integrity of cancer sci

Why returning to 'normal life' after cancer isn't medically simple

World Cancer Day 2026: Being declared cancer-free does not always mean full recovery, as oncologists explain why life after cancer often involves lasting physical, mental and emotional effects

World Cancer Day 2026: Theme explained, history, and why awareness matters

World Cancer Day 2026 marks February 4 with the theme 'United by Unique', tracing the day's history and underlining why prevention, screening and equitable access to cancer care matter worldwide

Spanish researchers report major pancreatic cancer breakthrough in mice

Scientists in Spain have reported a promising pancreatic cancer breakthrough in mice, where a triple-drug therapy eliminated tumours by targeting the KRAS pathway, one of deadliest cancer mechanisms

₹3.5 cr on cow dung cancer research: Science or waste of taxpayer money?

A state-funded cancer research project centred on cow-based remedies has triggered debate. Surgical oncologist explains what science says, what evidence is missing, and why accountability matters

Precision oncology gains ground as India clears targeted cancer therapies

A string of CDSCO approvals and reviews is accelerating India's move to immunotherapies, ADCs and targeted drugs, widening options in major cancers and boosting competition

Scientists edge closer to a universal cancer vaccine using nanoparticles

What if a single vaccine platform could train the immune system to prevent multiple cancers? A new nanoparti

French drugmaker Servier sharpens India strategy, eyes ₹1,000 cr revenue

Servier is stepping up its India push to bring first-in-class and precision medicines, expand global clinical research participation and use India for manufacturing and GCC services

HIV-free for seven years after cancer treatment, and doctors are amazed

A man treated for blood cancer has stayed HIV-free for seven years after a stem-cell transplant, even without the CCR5 mutation once seen as essential, shifting cure research

Cancer crisis intensifies globally, hitting low-resource countries hardest

Once seen as a disease of the wealthy, cancer now affects all regions, with a growing share of cases and deaths occurring in low- and middle-income countries

Datanomics: One in every 74 Indians at lifetime risk of lung cancer

Cancers of the respiratory system ranked fifth in India in 2022, with 1,43,062 reported cases. Digestive system cancers and breast cancer remained the top sites.

mRNA Covid shots could make cancer immunotherapy more effective, says study

Scientists have found that Covid-19 mRNA vaccines could enhance immune responses in cancer patients, potentially transforming how immunotherapy works